A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections

Condition:   Skin Infection Interventions:   Combination Product: 9MW1411 injection 1 combined with Linezolid;   Combination Product: 9MW1411 injection 2 combined with Linezolid;   Combination Product: 9MW1411 injection placebo combined with Linezolid Sponsor:   Mabwell (Shanghai) Bioscience Co., Ltd. Recruiting

Source: ClinicalTrials.gov - April 21, 2022 Category: Research Source Type: clinical trials